• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新兴的双重疾病负担:心血管疾病和癌症患者的患病率。

An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer.

机构信息

Department of Social and Behavioural Sciences, Harvard School of Public Health, Harvard University, Boston, MA, USA.

出版信息

J Intern Med. 2014 May;275(5):494-505. doi: 10.1111/joim.12165. Epub 2013 Dec 21.

DOI:10.1111/joim.12165
PMID:24372982
Abstract

OBJECTIVE

Cardiovascular disease (CVD) and cancer are the two leading causes of death in the United States; at the same time, the number of survivors is increasing as therapies continue to improve. The primary objective of this study is to determine the prevalence and characteristics of individuals affected by both CVD and cancer.

DESIGN AND SETTING

We conducted a prevalence study using the 2009 and 2010 national Behavioural Risk Factor Surveillance System population survey. Data from a random sample of individuals (aged 25-99 years) from all states were collected. All participants provided information regarding their CVD and cancer status. Multivariable regression identified associations between participants' characteristics and the prevalence of double disease burden.

RESULTS

Amongst 442,964 study participants, the overall prevalence rates were 11% for CVD and 15% for cancer; 3% of participants reported being survivors of both CVD and cancer. The prevalence of CVD+cancer increased twofold by 65 years of age (odds ratio [OR] 2.4, 95% confidence interval [CI] 2.3-2.5) and doubled again at ≥75 years (OR 4.9, 95% CI 4.6-5.1) and was higher amongst men (OR 1.6, 95% CI 1.6-1.7), multiracial individuals (OR 1.8, 95% CI 1.5-2.0) and those without a high school diploma (OR 1.3, 95% CI 1.2-1.4). Amongst individuals with CVD, 25% also reported having cancer, whilst 19% of all cancer survivors reported having CVD.

CONCLUSIONS

The prevalence of the double burden of disease increased with age; this is particularly important as the 'baby boomers' reach this high-risk age group. Future studies should explore potential common upstream or downstream mechanisms of CVD and cancer as well as public health strategies to cope with the double burden of disease.

摘要

目的

心血管疾病(CVD)和癌症是美国的两大主要死亡原因;同时,随着治疗方法的不断改进,幸存者的数量也在增加。本研究的主要目的是确定同时患有 CVD 和癌症的个体的患病率和特征。

设计和设置

我们使用 2009 年和 2010 年全国行为风险因素监测系统人群调查进行了一项患病率研究。从全美随机抽取的 25-99 岁个体的样本中收集数据。所有参与者均提供了 CVD 和癌症患病状况的信息。多变量回归分析确定了参与者特征与双重疾病负担患病率之间的关联。

结果

在 442964 名研究参与者中,CVD 的总体患病率为 11%,癌症的患病率为 15%;有 3%的参与者报告称患有 CVD 和癌症两种疾病。65 岁以上人群 CVD+癌症的患病率增加了两倍(优势比[OR] 2.4,95%置信区间[CI] 2.3-2.5),≥75 岁人群的患病率又增加了一倍(OR 4.9,95% CI 4.6-5.1),男性(OR 1.6,95% CI 1.6-1.7)、多种族人群(OR 1.8,95% CI 1.5-2.0)和未完成高中学业的人群(OR 1.3,95% CI 1.2-1.4)的患病率更高。在患有 CVD 的人群中,有 25%的人还报告患有癌症,而所有癌症幸存者中有 19%的人患有 CVD。

结论

随着年龄的增长,双重疾病负担的患病率增加;对于即将进入这个高风险年龄段的“婴儿潮一代”来说,这一点尤为重要。未来的研究应探讨 CVD 和癌症的潜在共同上游或下游机制,以及应对双重疾病负担的公共卫生策略。

相似文献

1
An emerging double burden of disease: the prevalence of individuals with cardiovascular disease and cancer.新兴的双重疾病负担:心血管疾病和癌症患者的患病率。
J Intern Med. 2014 May;275(5):494-505. doi: 10.1111/joim.12165. Epub 2013 Dec 21.
2
Burden of illness in cancer survivors: findings from a population-based national sample.癌症幸存者的疾病负担:基于全国人口样本的研究结果
J Natl Cancer Inst. 2004 Sep 1;96(17):1322-30. doi: 10.1093/jnci/djh255.
3
Prevalence of Cardiovascular Risk Factors Among Cancer Patients in the United States.美国癌症患者中心血管危险因素的流行情况。
Metab Syndr Relat Disord. 2019 Oct;17(8):397-405. doi: 10.1089/met.2018.0137. Epub 2019 Jun 26.
4
Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.心血管风险因素与睾丸癌长期幸存者的发病率:一项 20 年随访研究。
J Clin Oncol. 2010 Oct 20;28(30):4649-57. doi: 10.1200/JCO.2010.29.9362. Epub 2010 Sep 20.
5
Established cardiovascular disease and CVD risk factors in a primary care population of middle-aged Irish men and women.爱尔兰中年男性和女性初级保健人群中已确诊的心血管疾病和心血管疾病风险因素。
Ir Med J. 2002 Nov-Dec;95(10):298-301.
6
Women in Pakistan have a greater burden of clinical cardiovascular risk factors than men.巴基斯坦女性比男性承担着更大的临床心血管危险因素负担。
Int J Cardiol. 2006 Jan 26;106(3):348-54. doi: 10.1016/j.ijcard.2005.02.013.
7
Prevalence of cardiovascular disease in Gabon: a population study.加蓬心血管疾病的流行情况:一项人群研究。
Arch Cardiovasc Dis. 2012 Feb;105(2):77-83. doi: 10.1016/j.acvd.2011.12.005. Epub 2012 Mar 2.
8
Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals.超重和肥胖个体中亚临床心血管疾病的负担及预后重要性
Circulation. 2007 Jul 24;116(4):375-84. doi: 10.1161/CIRCULATIONAHA.107.688788. Epub 2007 Jul 9.
9
Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.葡萄牙的代谢综合征:患病率及其对心血管风险的影响——VALSIM研究结果
Rev Port Cardiol. 2008 Dec;27(12):1495-529.
10
Prevalence and risk factors of cardiovascular disease (CVD) events among patients with haemophilia: experience of a single haemophilia treatment centre in the United States (US).血友病患者心血管疾病(CVD)事件的患病率和危险因素:美国(US)单一家血有病治疗中心的经验。
Haemophilia. 2011 Jul;17(4):597-604. doi: 10.1111/j.1365-2516.2010.02463.x. Epub 2011 Feb 15.

引用本文的文献

1
Muscle Proteome Dynamics.肌肉蛋白质组动力学
Adv Exp Med Biol. 2025;1478:113-153. doi: 10.1007/978-3-031-88361-3_7.
2
Prognostic impact of cancer history in patients undergoing transcatheter mitral valve repair.癌症病史对行经导管二尖瓣修复术患者的预后影响。
Clin Res Cardiol. 2024 Jan;113(1):94-106. doi: 10.1007/s00392-023-02266-5. Epub 2023 Aug 15.
3
Transcatheter edge-to-edge repair in patients with a history of cancer: Can we proceed, or is it too early to tell?有癌症病史患者的经导管缘对缘修复术:我们能进行吗?还是现在下结论为时过早?
Int J Cardiol Heart Vasc. 2023 Jan 23;44:101178. doi: 10.1016/j.ijcha.2023.101178. eCollection 2023 Feb.
4
Cancer and cardiovascular-related perceived risk in a diverse cancer center catchment area.癌症和心血管相关的感知风险在一个多样化的癌症中心集水区。
Cancer Causes Control. 2022 May;33(5):759-768. doi: 10.1007/s10552-022-01560-3. Epub 2022 Mar 11.
5
Neoplasms and the Evaluation of Risk of Cardiovascular Disease.肿瘤与心血管疾病风险评估
Arq Bras Cardiol. 2022 Feb;118(2):486-487. doi: 10.36660/abc.20220007.
6
Developing Faith-Based Health Promotion Programs that Target Cardiovascular Disease and Cancer Risk Factors.开发以心血管疾病和癌症风险因素为目标的基于信仰的健康促进项目。
J Relig Health. 2022 Apr;61(2):1318-1332. doi: 10.1007/s10943-021-01469-2. Epub 2021 Dec 1.
7
Predictive Value of the Platelet-to-Lymphocyte Ratio in Cancer Patients Undergoing Transcatheter Aortic Valve Replacement.血小板与淋巴细胞比值在接受经导管主动脉瓣置换术的癌症患者中的预测价值
JACC CardioOncol. 2019 Dec 17;1(2):159-169. doi: 10.1016/j.jaccao.2019.10.004. eCollection 2019 Dec.
8
F-FDG-PET/CT in the assessment of atherosclerosis in lung cancer.F-FDG-PET/CT在肺癌动脉粥样硬化评估中的应用
Am J Nucl Med Mol Imaging. 2021 Feb 15;11(1):1-9. eCollection 2021.
9
Impact of cancer history on clinical outcome in patients undergoing transcatheter edge-to-edge mitral repair.癌症病史对行经皮缘对缘二尖瓣修复术患者临床结局的影响。
Clin Res Cardiol. 2021 Mar;110(3):440-450. doi: 10.1007/s00392-020-01770-2. Epub 2020 Nov 9.
10
Impact of pre-existing cardiovascular disease on treatment patterns and survival outcomes in patients with lung cancer.预先存在的心血管疾病对肺癌患者治疗模式和生存结果的影响。
BMC Cancer. 2020 Oct 15;20(1):1004. doi: 10.1186/s12885-020-07487-9.